Jillian Petrera and I are pleased to be joining the Association of National Advertisers next week to discuss Cannabis and CBD marketing...
Reed Smith LLP
viewpoints
Welcome to Reed Smith's viewpoints — timely commentary from our lawyers on topics relevant to your business and wider industry. Browse to see the latest news and subscribe to receive updates on topics that matter to you, directly to your mailbox.
FDA announced on 3/11 that it has reopened its public docket to encourage stakeholders to provide scientific data and information about...
FDA had 60 days from December 20 to issue a report to Congress regarding the Agency's progress toward obtaining and analyzing data to...
In our August 2019 client alert, we highlighted the fact that the EU had added a new entry for cannabinoids to the Novel Food Catalogue...
U.S. companies seeking to ship marijuana -- or even CBD products -- by U.S. mail or other common carrier need to be cognizant of those...
Will CBD soon be allowed in foods and dietary supplements? A group of congressmen certainly hope so. As things currently stand, because...
Reports are in that many large companies have stalled the production of edible products containing CBD in light of FDA warnings about...
New regulations governing the production of hemp in Pennsylvania went into effect in 2020. They are designed to keep levels of THC-the...
The suits just keep coming. FDA sent a Warning Letter to Koi CBD earlier this month (along with 14 other companies) because of its...
As anticipated, additional class action lawsuits have been filed against two more CBD companies, both in federal court in California. As...
FDA has made good on its promise to continue enforcing against companies selling CBD products that violate the Federal Food, Drug, and...
Cannabis-related travel issues continue to arise. Previously, after the act passing the legalization of adult-use cannabis across Canada,...